NASDAQ: RANIRani Therapeutics Holdings Inc Stock Ownership - Who owns Rani Therapeutics Holdings?
Insider buying vs selling
Have Rani Therapeutics Holdings Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Talat Imran | Chief Executive Officer | 2023-12-06 | 10,000 | $2.27 | $22.70kBuy |
| Talat Imran | Chief Executive Officer | 2023-12-04 | 5,000 | $2.57 | $12.85kBuy |
| Talat Imran | Chief Executive Officer | 2023-11-29 | 20,000 | $2.05 | $41.00kBuy |
| South Cone Investments Limited Partnership | 10% Owner | 2023-11-24 | 5,265,165 | $2.01 | $10.58MBuy |
| Cortes Isidoro Alfonso Quiroga | 10% Owner | 2023-11-24 | 5,265,165 | $2.01 | $10.58MSell |
| Jean Luc Butel | Director | 2023-11-17 | 50,500 | $2.03 | $102.51kBuy |
| Maulik Nanavaty | Director | 2023-11-16 | 500 | $1.98 | $990.00Buy |
| Talat Imran | Chief Executive Officer | 2023-11-07 | 2,500 | $1.98 | $4.95kBuy |
| Talat Imran | Chief Executive Officer | 2023-11-07 | 2,500 | $2.01 | $5.02kBuy |
| South Cone Investments Limited Partnership | 10% Owner | 2023-05-12 | 2,645 | $3.98 | $10.53kBuy |
RANI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RANI insiders and whales buy or sell their stock.
RANI Shareholders
What type of owners hold Rani Therapeutics Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| South Cone Investments Limited Partnership | 37.34% | 18,728,042 | $132.41M | Insider |
| Moreno Isidoro Quiroga | 10.51% | 5,272,750 | $37.28M | Insider |
| Vanguard Group Inc | 1.33% | 668,347 | $4.73M | Institution |
| Talat Imran | 0.99% | 496,798 | $3.51M | Insider |
| Nan Fung Group Holdings Ltd | 0.98% | 493,584 | $3.49M | Institution |
| United Services Automobile Association | 0.96% | 481,300 | $3.40M | Institution |
| Alphabet Inc | 0.89% | 448,492 | $3.17M | Institution |
| Andrew Farquharson | 0.81% | 406,768 | $2.88M | Insider |
| Mir Hashim | 0.54% | 273,265 | $1.93M | Insider |
| Svai S. Sanford | 0.52% | 258,597 | $1.83M | Insider |
RANI vs Biotech Stocks
Rani Therapeutics Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.